Ann Allen
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria 4
- Pharmacology top 5%
- Antibiotics Pharmacokinetics and Efficacy 7
- Physiology top 5%
- Asthma and respiratory diseases 26
- Pharmacology top 5%
- Antibiotics Pharmacokinetics and Efficacy 7
-
- Inhalation and Respiratory Drug Delivery 18
- Respiratory and Cough-Related Research 9
-
- Pharmacological Effects and Assays 6
-
- Pneumonia and Respiratory Infections 5
-
- Radiopharmaceutical Chemistry and Applications 4
Ann Allen
45 papers receiving 828 citations
Peers
Comparison fields: 5 of 84
- Molecular Medicine 89
- Pharmacology 148
- Physiology 377
- Pharmacology 233
- Pulmonary and Respiratory Medicine 396
Countries citing papers authored by Ann Allen
This map shows the geographic impact of Ann Allen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann Allen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann Allen more than expected).
Fields of papers citing papers by Ann Allen
This network shows the impact of papers produced by Ann Allen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann Allen. The network helps show where Ann Allen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ann Allen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 1 | |
| 2 | 2015 | 9 | |
| 3 | 2015 | 17 | |
| 4 | 2014 | 15 | |
| 5 | Pharmacokinetics of orally administered rucaparib in patients with advanced solid tumors. | 2013 | 3 |
| 6 | 2013 | 26 | |
| 7 | 2013 | 14 | |
| 8 | 2012 | 75 | |
| 9 | 2012 | 17 | |
| 10 | 2012 | 23 | |
| 11 | 2011 | 13 | |
| 12 | 2008 | 32 | |
| 13 | 2007 | 39 | |
| 14 | 1999 | 12 | |
| 15 | 1999 | 18 | |
| 16 | 1999 | 31 | |
| 17 | 1999 | 16 | |
| 18 | 1999 | 22 | |
| 19 | 1993 | 14 | |
| 20 | 1992 | 173 |
About Ann Allen
Ann Allen is a scholar working on Physiology, Molecular Medicine, Pulmonary and Respiratory Medicine, Animal Science and Zoology and Immunology and Allergy, having authored 45 papers that have together received 873 indexed citations. Recurring topics across this work include Asthma and respiratory diseases (26 papers), Inhalation and Respiratory Drug Delivery (18 papers), Respiratory and Cough-Related Research (9 papers), Antibiotics Pharmacokinetics and Efficacy (7 papers), Pharmacological Effects and Assays (6 papers), Pneumonia and Respiratory Infections (5 papers), Radiopharmaceutical Chemistry and Applications (4 papers) and Antibiotic Resistance in Bacteria (4 papers). The work is most often cited by research in Molecular Medicine (89 citations), Pharmacology (148 citations), Physiology (377 citations), Pharmacology (233 citations) and Pulmonary and Respiratory Medicine (396 citations). Ann Allen has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Rodger Kempsford, Philippe Bareille, Jesper Hallas, Søren H. Sindrup, Graham Allen, Lars F. Gram, G. Mellows, Barry D. Zussman, Erik Skjelbo and Kim Brøsen. Their work appears in journals such as Chemotherapy, Journal of Clinical Oncology, Clinical Therapeutics, British Journal of Clinical Pharmacology and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.